167 related articles for article (PubMed ID: 2653518)
1. Etoposide: fifteen years experience.
Bernasconi C
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():52-5. PubMed ID: 2653518
[No Abstract] [Full Text] [Related]
2. Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.
Romani C; Di Tucci AA; Dessalvi P; Pettinau M; Emanuele A
Am J Hematol; 2010 Mar; 85(3):219. PubMed ID: 20063278
[No Abstract] [Full Text] [Related]
3. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
[No Abstract] [Full Text] [Related]
4. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
Tsukaguchi M; Furukawa Y; Shibano M; Kitani T
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
[TBL] [Abstract][Full Text] [Related]
5. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
[No Abstract] [Full Text] [Related]
6. Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia.
Rowe JM; Mazza JJ; Hines JD; Cassileth PA; Oken MM; Bennett JM; Andersen J
Haematol Blood Transfus; 1990; 33():326-9. PubMed ID: 2182427
[No Abstract] [Full Text] [Related]
7. Treatment of relapsed and refractory acute myeloid leukemia in adults.
Lazzarino M; Morra E; Alessandrino EP; Merante S; Bernasconi P; Bonfichi M; Caldera D; Bernasconi C
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():121-3. PubMed ID: 2653487
[No Abstract] [Full Text] [Related]
8. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
[TBL] [Abstract][Full Text] [Related]
9. Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia.
Ehninger G; Fackler-Schwalbe E; Freund M; Heil G; Henke M; Hoelzer D; Hoffmann R; Kurrle E; Link H; Lösch A
Haematol Blood Transfus; 1990; 33():316-7. PubMed ID: 2182425
[No Abstract] [Full Text] [Related]
10. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
[TBL] [Abstract][Full Text] [Related]
11. Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
Lee SS; Lee JH; Lee JH; Kim DY; Kim SH; Lim SN; Lee YS; Seol M; Ryu SG; Kang YA; Jang S; Park CJ; Chi HS; Yun SC; Lee KH
Leuk Res; 2009 Apr; 33(4):511-7. PubMed ID: 18819710
[TBL] [Abstract][Full Text] [Related]
12. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
13. [Childhood acute myeloblastic leukemias. Report of 21 cases].
Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Sweet's syndrome and the pathergy phenomenon.
Awan F; Hamadani M; Devine S
Ann Hematol; 2007 Aug; 86(8):613-4. PubMed ID: 17468870
[No Abstract] [Full Text] [Related]
15. Cardiac tamponade as the initial manifestation of acute leukemia: report of a case and review of the literature.
Batlle M; Ribera JM; Larrousse E; Abella E; Las Heras G; Milla F; Junca J
Haematologica; 1991; 76(6):505-7. PubMed ID: 1820988
[TBL] [Abstract][Full Text] [Related]
16. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J
Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of relapsed AML and ALL].
Nishikawa K
Rinsho Ketsueki; 1996 Aug; 37(8):647-50. PubMed ID: 8827871
[No Abstract] [Full Text] [Related]
18. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
20. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
Carella AM; Pungolino E; Piatti G; Giordano D; Cerri R; Risso M; Nati S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
